SARcode Bioscience Announces Acquisition by Shire US Holdings

SARcode Bioscience, Inc., an ophthalmic biopharmaceutical company, announced today that it will be acquired by Shire US Holdings Inc., a global specialty biopharmaceutical company focused on enabling people with lifealtering conditions to lead better lives. SARcode's lead program, lifitegrast ophthalmic solution, is cu...

Full Story →